Last $327.90 USD
Change Today +1.01 / 0.31%
Volume 900.7K
As of 3:36 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Scangos Ph.D.

Chief Executive Officer and Director, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 131 board members in 7 different organizations across 10 different industries.

See Board Relationships
66$15,015,147
As of Fiscal Year 2013

Background*

Dr. George A. Scangos, Ph.D. has been the Chief Executive Officer at Biogen Idec Inc. since July 2010. Dr. Scangos served as the President and Chief Executive Officer of Exelixis Inc., a holding company of X-ceptor Therapeutics Inc. from October 1996 to July 2010. He served as the President of Biotechnology of Bayer Corporation from September 1993 to October 1996 and was responsible for 1,100 employees in research and development, business development, process development, ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-2000
Fax: --

Board Members Memberships*

Vice Chairman
Director
Director
Director
1996-Present
Director
1997-N/A
Former Non-Executive Director and Member of Remuneration Committee
2000-2005
Former Director
2003-N/A
Former Chairman and Member of Compensation Committee
2010-Present
Chief Executive Officer and Director
2014-Present
Director

Education*

BA
Cornell University
PhD
University Of Massachusetts

Other Affiliations*

Annual Compensation*

Salary$1,498,462
Total Annual Compensation$1,498,462

Stock Options*

Restricted Stock Awards$9,195,217
All Other Compensation$671,511

Total Compensation*

Total Annual Cash Compensation$5,730,453
Total Short Term Compensation$1,498,462
Other Long Term Compensation$9,866,728
Total Calculated Compensation$15,015,147
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $327.91 USD +1.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.1M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.